Business Context and Reporting Period
This Form 8-K is a current report filed by RYVYL Inc. (noting the input metadata reference to "RTB Digital, Inc." appears to be a discrepancy with the filing text) on September 18, 2025. The report details the completion of the sale of the Company's indirect subsidiary, Ryvyl (EU) EAD ("Ryvyl EU"), a Bulgarian entity. The transaction was originally announced in January 2025 and involved a complex series of agreements regarding termination rights and standstill periods.
Key Financial Metrics and Transaction Details
- Transaction Type: Sale of 100% of issued and outstanding shares of Ryvyl EU.
- Original Purchase Price: $15,000,000 (per the January 23, 2025 Stock Purchase Agreement).
- Termination Fee Obligation: $16,500,000 (initially required to terminate the sale agreement).
- Extension Payments: $500,000 (for a 30-day extension) and $750,000 (for a further extension to May 27, 2025).
- Financial Statements: The filing references Unaudited Pro Forma Financial Information attached as Exhibit 99.1 but does not contain specific revenue, profit, cash flow, or debt figures for the reporting period within the text provided.
Material Changes and Transaction History
The filing outlines a significant evolution in the disposition of Ryvyl EU:
- January 2025: Entered into a Stock Purchase Agreement (SPA) to sell Ryvyl EU for $15 million. Simultaneously entered a Termination Agreement allowing the Company to buy back the sale rights for $16.5 million by April 23, 2025.
- April 2025: Executed a Modification Agreement delaying the closing until May 6, 2025, to explore alternative transactions. The Company paid $750,000 to extend the standstill period to May 27, 2025.
- May 2025: The Company did not exercise its right to terminate the SPA by paying the $16.5 million fee, nor did it extend the standstill period. The Purchaser notified the Company that the termination right had expired and the standstill period ended.
- June 2025: The Purchaser issued a letter stating that the Company's obligation to pay the $16.5 million damages or any other amount under the SPA ceased to apply.
- Completion: The Company confirms the sale of Ryvyl EU was completed as reported in prior S-1 Amendments.
Outlook, Risks, and Management Commentary
The filing includes standard forward-looking statements regarding the Company's future expectations. Key risks and contingencies highlighted include:
- Nasdaq Compliance: Risks related to meeting the Majority Independent Board Requirement and Audit Committee Composition Requirement.
- Delisting Risk: The possibility that the Company may not meet continued listing requirements under Nasdaq Listing Rules or that Nasdaq may not grant relief from delisting.
- Uncertainty: Actual results may differ materially from projections due to factors beyond the Company's control.
Investor Verification Checklist
- Verify the final closing terms and actual consideration received for the Ryvyl EU sale, as the text confirms completion but does not explicitly state the final cash proceeds in this specific 8-K body.
- Confirm the status of the $16.5 million termination fee obligation; the text states the Purchaser waived this in June 2025, but investors should verify no subsequent legal disputes arose.
- Review the Unaudited Pro Forma Financial Information in Exhibit 99.1 (referenced but not included in this text) to understand the impact of the divestiture on the Company's financial position.
- Monitor the Company's progress in meeting Nasdaq listing requirements regarding board independence and audit committee composition.